Copyright Reports & Markets. All rights reserved.

Global Opioids Agonist Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Opioids Agonist Drugs Market Overview

      • 1.1 Product Overview and Scope of Opioids Agonist Drugs
      • 1.2 Opioids Agonist Drugs Segment by Type
        • 1.2.1 Global Opioids Agonist Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Codeine
        • 1.2.3 Fentanyl
        • 1.2.4 Meperidine
        • 1.2.5 Methadone
        • 1.2.6 Morphine
        • 1.2.7 Hydrocodone
      • 1.3 Opioids Agonist Drugs Segment by Application
        • 1.3.1 Opioids Agonist Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Pain Management
        • 1.3.3 Cough Treatment
        • 1.3.4 Diarrhea Treatment
      • 1.4 Global Opioids Agonist Drugs Market by Region
        • 1.4.1 Global Opioids Agonist Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Opioids Agonist Drugs Market Size
        • 1.5.1 Global Opioids Agonist Drugs Revenue (2014-2025)
        • 1.5.2 Global Opioids Agonist Drugs Production (2014-2025)

      2 Global Opioids Agonist Drugs Market Competition by Manufacturers

      • 2.1 Global Opioids Agonist Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Opioids Agonist Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Opioids Agonist Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Opioids Agonist Drugs Production Sites, Area Served, Product Types
      • 2.5 Opioids Agonist Drugs Market Competitive Situation and Trends
        • 2.5.1 Opioids Agonist Drugs Market Concentration Rate
        • 2.5.2 Opioids Agonist Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Opioids Agonist Drugs Production Market Share by Regions

      • 3.1 Global Opioids Agonist Drugs Production Market Share by Regions
      • 3.2 Global Opioids Agonist Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Opioids Agonist Drugs Production
        • 3.4.1 North America Opioids Agonist Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Opioids Agonist Drugs Production
        • 3.5.1 Europe Opioids Agonist Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Opioids Agonist Drugs Production (2014-2019)
        • 3.6.1 China Opioids Agonist Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Opioids Agonist Drugs Production (2014-2019)
        • 3.7.1 Japan Opioids Agonist Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Opioids Agonist Drugs Consumption by Regions

      • 4.1 Global Opioids Agonist Drugs Consumption by Regions
      • 4.2 North America Opioids Agonist Drugs Consumption (2014-2019)
      • 4.3 Europe Opioids Agonist Drugs Consumption (2014-2019)
      • 4.4 China Opioids Agonist Drugs Consumption (2014-2019)
      • 4.5 Japan Opioids Agonist Drugs Consumption (2014-2019)

      5 Global Opioids Agonist Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Opioids Agonist Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Opioids Agonist Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Opioids Agonist Drugs Price by Type (2014-2019)
      • 5.4 Global Opioids Agonist Drugs Production Growth by Type (2014-2019)

      6 Global Opioids Agonist Drugs Market Analysis by Applications

      • 6.1 Global Opioids Agonist Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Opioids Agonist Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Opioids Agonist Drugs Business

      • 7.1 Purdue Pharma
        • 7.1.1 Purdue Pharma Opioids Agonist Drugs Production Sites and Area Served
        • 7.1.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.1.3 Purdue Pharma Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Titan pharmaceuticals
        • 7.2.1 Titan pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
        • 7.2.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.2.3 Titan pharmaceuticals Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Boehringer Ingelheim
        • 7.3.1 Boehringer Ingelheim Opioids Agonist Drugs Production Sites and Area Served
        • 7.3.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.3.3 Boehringer Ingelheim Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Janssen Pharmaceuticals, Inc
        • 7.4.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production Sites and Area Served
        • 7.4.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Sanofi
        • 7.5.1 Sanofi Opioids Agonist Drugs Production Sites and Area Served
        • 7.5.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.5.3 Sanofi Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sun Pharmaceuticals
        • 7.6.1 Sun Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
        • 7.6.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Mallinckrodt Pharmaceuticals
        • 7.7.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
        • 7.7.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Egalet Corporation
        • 7.8.1 Egalet Corporation Opioids Agonist Drugs Production Sites and Area Served
        • 7.8.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.8.3 Egalet Corporation Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Endo Pharmaceuticals Inc.
        • 7.9.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production Sites and Area Served
        • 7.9.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Allergan, Plc
        • 7.10.1 Allergan, Plc Opioids Agonist Drugs Production Sites and Area Served
        • 7.10.2 Opioids Agonist Drugs Product Introduction, Application and Specification
        • 7.10.3 Allergan, Plc Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Pfizer Inc

      8 Opioids Agonist Drugs Manufacturing Cost Analysis

      • 8.1 Opioids Agonist Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Opioids Agonist Drugs
      • 8.4 Opioids Agonist Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Opioids Agonist Drugs Distributors List
      • 9.3 Opioids Agonist Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Opioids Agonist Drugs Market Forecast

      • 11.1 Global Opioids Agonist Drugs Production, Revenue Forecast
        • 11.1.1 Global Opioids Agonist Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Opioids Agonist Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Opioids Agonist Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Opioids Agonist Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Opioids Agonist Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Opioids Agonist Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Opioids Agonist Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Opioids Agonist Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Opioids Agonist Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Opioids Agonist Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Opioids Agonist Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
        Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth

        The global Opioids Agonist Drugs market is valued at 18600 million US$ in 2018 is expected to reach 25900 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2019-2025.
        This report focuses on Opioids Agonist Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Opioids Agonist Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Purdue Pharma
        Titan pharmaceuticals
        Boehringer Ingelheim
        Janssen Pharmaceuticals, Inc
        Sanofi
        Sun Pharmaceuticals
        Mallinckrodt Pharmaceuticals
        Egalet Corporation
        Endo Pharmaceuticals Inc.
        Allergan, Plc
        Pfizer Inc

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Codeine
        Fentanyl
        Meperidine
        Methadone
        Morphine
        Hydrocodone

        Segment by Application
        Pain Management
        Cough Treatment
        Diarrhea Treatment

        Buy now